Original Article

Clinical Features of Untreated Type 2 Macular Telangiectasia and Efficacy of Anti-Vascular Endothelial Growth Factor Therapy in Macular Neovascularization
  • Müge Çoban Karataş
  • Gürsel Yılmaz
  • Aslıhan Yüce Sezen
  • Çağla Sarıtürk
Turk J Ophthalmol 2022; 52: 45-49 DOI: 10.4274/tjo.galenos.2021.75608 PMID:35196839
Intravitreal Bevacizumab Treatment in Type 2 Idiopathic Macular Telangiectasia
  • Tuğba Aydoğan
  • Gürkan Erdoğan
  • Cihan Ünlü
  • Ahmet Ergin
Turk J Ophthalmol 2016; 46: 270-273 DOI: 10.4274/tjo.23921 PMID:28050323
Optical Coherence Tomography Angiography Findings in Type-2 Macular Telangiectasia
  • Hilal Nalcı
  • Figen Şermet
  • Sibel Demirel
  • Emin Özmert
Turk J Ophthalmol 2017; 47: 279-284 DOI: 10.4274/tjo.68335 PMID:29109897